Altria Trades at a Bargain: Is it a Good Time to Buy the Stock?

Altria (MO) is trading at a forward P/E of 10.81, significantly below its industry average and the S&P 500, suggesting it is undervalued. Despite recent underperformance relative to peers, Altria's Q1 2025 saw an 18% increase in on! shipments, gaining market share in oral tobacco and nicotine pouches, and EPS estimates have been revised upwards, projecting 5.3% year-over-year growth for 2025. The company's strategic shift towards smoke-free products and pricing power, combined with a Zacks Rank #2 (Buy), indicates a potential opportunity for value-focused investors.

Analysis

Altria Group, Inc. (MO) presents a compelling valuation case, trading at a forward 12-month price-to-earnings (P/E) ratio of 10.81, significantly below the industry average of 15.73 and the S&P 500's 21.85. This undervaluation is further highlighted when compared to competitors like Philip Morris (PM) at 21.18 and Turning Point Brands (TPB) at 21.07, though British American Tobacco (BTI) trades at a comparable P/E of 10.49. Despite this attractive valuation, MO's stock has gained only 1.8% over the past three months, underperforming the industry's 17.1% growth and key competitors. However, the stock currently trades above its 50-day and 200-day moving averages, suggesting underlying bullish momentum. Strategically, Altria is advancing its smoke-free transition, with its oral nicotine pouch brand 'on!' experiencing an 18% year-over-year shipment increase in Q1 2025, reaching over 39 million cans and capturing 8.8% of the oral tobacco category and 17.9% of the nicotine pouch market. This growth in reduced-risk products, coupled with sustained pricing power in traditional segments, supported revenue growth in Q1. Altria projects 2025 adjusted EPS between $5.30 and $5.45, representing up to 5% YoY growth. Analyst sentiment is positive, with the Zacks Consensus Estimate for current year EPS revised upward by 4 cents to $5.39 and for next year by 1 cent to $5.55, implying expected EPS growth of 5.3% this year and 3% next year. The company's 'Optimize & Accelerate' initiative aims to enhance efficiency and fund its smoke-free transformation, including retooling its NJOY e-vapor platform.

Key Decisions for Investors

• Investors may consider MO as a value opportunity given its discounted P/E ratio relative to peers and the market, coupled with positive EPS growth projections and upward analyst revisions.
• Monitor the continued market share gains and shipment growth of Altria's 'on!' brand as a key indicator of its successful transition to smoke-free products, which is crucial for long-term performance.
• While the stock's recent underperformance relative to the industry could be a buying opportunity, investors should also weigh this against the persistent regulatory headwinds and competitive pressures within the tobacco sector.